TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
N4 Pharma ( (GB:N4P) ) has provided an update.
N4 Pharma plc announced an Investor Insight Event for retail investors, scheduled for July 14, 2025, at the Royal College of Surgeons in London. The event aims to provide a strategic update on the development of Nuvec® as a delivery system for RNA therapeutics, featuring presentations from the CEO and senior leadership team, followed by a Q&A session and networking lunch. This initiative highlights the company’s commitment to engaging with stakeholders and advancing its position in the biotech industry.
More about N4 Pharma
N4 Pharma plc is a UK-based biotechnology company focused on developing Nuvec®, a proprietary gene delivery system designed to enhance advanced therapies for cancer and other diseases.
Average Trading Volume: 1,718,567
Technical Sentiment Signal: Sell
Current Market Cap: £5.71M
For a thorough assessment of N4P stock, go to TipRanks’ Stock Analysis page.